Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 18476819)

1.

The use of Endo-Porter to deliver morpholinos in kidney organ culture.

Nikopoulos GN, Adams TL, Adams D, Oxburgh L, Prudovsky I, Verdi JM.

Biotechniques. 2008 Apr;44(4):547-9. doi: 10.2144/000112725.

2.

Gene knockdowns in adult animals: PPMOs and vivo-morpholinos.

Moulton JD, Jiang S.

Molecules. 2009 Mar 25;14(3):1304-23. doi: 10.3390/molecules14031304. Review.

3.

Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides.

Thierry AR, Abes S, Resina S, Travo A, Richard JP, Prevot P, Lebleu B.

Biochim Biophys Acta. 2006 Mar;1758(3):364-74. Epub 2005 Nov 18. Review.

4.

Morpholino oligos: making sense of antisense?

Heasman J.

Dev Biol. 2002 Mar 15;243(2):209-14. Review.

PMID:
11884031
5.

Antisense approaches for investigating mechanisms of abnormal development.

Augustine K.

Mutat Res. 1997 Dec 12;396(1-2):175-93. Review.

PMID:
9434868
6.

Targeting the expression of anti-apoptotic proteins by antisense oligonucleotides.

Delihas N.

Curr Drug Targets. 2001 Jun;2(2):167-80. Review.

PMID:
11469717
7.

In vivo delivery of morpholino oligos by cell-penetrating peptides.

Moulton HM.

Curr Pharm Des. 2013;19(16):2963-9. Review.

PMID:
23140456
8.

[Exon skipping therapy for Duchenne muscular dystrophy by using antisense Morpholino].

Takeda S.

Rinsho Shinkeigaku. 2009 Nov;49(11):856-8. Review. Japanese.

PMID:
20030230
9.

Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.

Warzocha K, Wotowiec D.

Leuk Lymphoma. 1997 Jan;24(3-4):267-81. Review.

PMID:
9156656
10.

Controlled delivery of antisense oligonucleotides: a brief review of current strategies.

Zhao X, Pan F, Holt CM, Lewis AL, Lu JR.

Expert Opin Drug Deliv. 2009 Jul;6(7):673-86. doi: 10.1517/17425240902992894. Review.

PMID:
19552611
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk